Core Insights - The healthcare sector has become a significant area for Chinese companies investing in Southeast Asia, with direct investment transactions exceeding $6.619 billion from 2015 to 2023 [2] - Indonesia, as the largest economy in Southeast Asia with a population of approximately 280 million, presents substantial market opportunities, particularly in healthcare, with estimated healthcare spending reaching IDR 677 trillion (approximately $47 billion) by 2024 [2] - A series of themed activities have been launched to help Chinese enterprises seize opportunities in the Indonesian market, focusing on the growth potential and policy incentives in the healthcare sector [2][3] Investment Environment - The Indonesian government emphasizes improving the investment environment under the "Golden Indonesia 2045 Vision," targeting nine priority sectors, including healthcare [5] - New policies have been introduced to simplify the investment process, including the "Omnibus Law" which revises 79 laws across 11 industry clusters, streamlining licensing processes and establishing an online submission system [5] - The government is also focused on providing clear land guarantees and facilitating local partnerships for investors [5] Market Entry Strategy - A five-step approach for companies looking to enter the Indonesian healthcare market includes understanding investment opportunities and policies, establishing a company, registering through the OSS online system, applying for tax incentives, and starting project operations [7][8] - The healthcare market in Indonesia is characterized by a growing middle class willing to pay for healthcare services, alongside significant demand due to inadequate modern medical infrastructure in eastern regions [8] Industry Development - Indonesia's pharmaceutical and medical device sectors are expanding, with over 1,200 pharmaceutical distributors and 800 medical device manufacturers [9] - The government is creating a favorable business environment for local production in pharmaceuticals and medical devices, offering incentives such as tax holidays and import duty reductions [9] - Local manufacturing compliance, such as the TKDN certification, poses challenges for foreign investors, who are encouraged to utilize local supply chains to reduce costs and enhance efficiency [9][10] Challenges and Recommendations - Foreign healthcare companies must register medical devices in Indonesia, requiring safety and efficacy evaluations by the Ministry of Health before sales can commence [10] - The government is issuing special permits for foreign doctors to practice in designated healthcare tourism zones, indicating a push towards developing medical tourism [8]
36氪出海·洞察｜解码印尼医疗投资新机遇：政策红利下的本地化策略
3 6 Ke·2025-06-05 11:30